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Abstract: Hydrogel application feasibility is still limited mainly due to their low mechanical strength
and fragile nature. Therefore, several physical and chemical cross-linking modifications are being
used to improve their properties. In this research, methacrylated Kefiran was synthesized by reacting
Kefiran with methacrylic anhydride (MA). The developed MA-Kefiran was physicochemically char-
acterized, and its biological properties evaluated by different techniques. Chemical modification of
MA-Kefiran was confirmed by 1H-NMR and FTIR and GPC-SEC showed an average Mw of 793 kDa
(PDI 1.3). The mechanical data obtained revealed MA-Kefiran to be a pseudoplastic fluid with an ex-
trusion force of 11.21 ± 2.87 N. Moreover, MA-Kefiran 3D cryogels were successfully developed and
fully characterized. Through micro-CT and SEM, the scaffolds revealed high porosity (85.53 ± 0.15%)
and pore size (33.67 ± 3.13 µm), thick pore walls (11.92 ± 0.44 µm) and a homogeneous structure.
Finally, MA-Kefiran revealed to be biocompatible by presenting no hemolytic activity and an im-
proved cellular function of L929 cells observed through the AlamarBlue® assay. By incorporating
methacrylate groups in the Kefiran polysaccharide chain, a MA-Kefiran product was developed with
remarkable physical, mechanical, and biological properties, resulting in a promising hydrogel to be
used in tissue engineering and regenerative medicine applications.
Keywords: biomedical applications; chemical cross-linking; hydrogel; Kefiran; methacrylation
1. Introduction
Achieving translational medicine together with commercial success requires regen-
erative polymers to be not only safe and appropriate but also cost-effective and suitable
for production and biomedical/clinical use. Tissue engineering and regenerative medicine
(TERM) strategies have shown to be promising to regenerate damaged tissues and to help
regain normal body functions [1]. Biodegradable natural polymers are currently widely
used for engineered tissue devices with their unique structural and compositional similari-
ties with the natural extracellular matrix (ECM). A key advantage of using these polymers
is their capability to successfully promote cell growth in vitro and regenerate tissue in vivo,
without toxicity or immunological reactions, which make them attractive for TERM strate-
gies [2,3]. Hydrogels have received significant attention in the TERM field, principally due
to their ability to be 3D biological materials that mimic aspects of a certain ECM so that
the tissue’s functions can be improved, maintained, or restored [4]. A main advantage of
hydrogels is their ability to fully recreate in situ the complexity of a tissue defect. Being
polymeric networks with high-water content, 3D hydrogels have played a pivotal microen-
vironment for cell colonization with their mechanical and biochemical properties [5]. In
the last decade, engineered 3D scaffolds have been successfully produced through several
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techniques such as phase separation [6], lithography [7], freeze-drying [8], cryogelation [9],
salt leaching [10], gas foaming (supercritical CO2 drying) [11,12], among others. It is im-
portant to highlight that when using water as solvent for scaffold fabrication, a special care
is needed regarding pore collapse upon its removal. As such, either supercritical [13] or
freeze–drying [8] is normally used to guarantee pore stabilization within the final porous
biomaterials [12].
Though, the feasibility of applying hydrogels is still limited including the fact that
they have low mechanical strength and a fragile nature. Therefore, new approaches are
being investigated to improve the in vivo application of hydrogels, including physical
and/or chemical cross-linking to enhance these properties, as well as functionalization to
better mimic the native extracellular environment [14].
Physical and chemical cross-linking mechanisms have been achieved for several natural-
origin hydrogels, such as agar, alginate, gelatin, gellan gum, and hyaluronic acid [4].
Regarding the physical synthesizing method, hydrogen bond formation, hydrophobic interac-
tion, and ionic interaction were the most used; on the other side, the chemical cross-linking
approach that relies on covalent bond formation includes different polymerization meth-
ods such as step-growth polymerization, irradiation polymerization, and chain-growth
polymerization [15]. A suitable hydrogel for biomedical applications demands specific
important criteria that will define the final properties of the device such as elasticity and
mechanical strength. Furthermore, the new material needs to be biocompatible and non-
cytotoxic to the corresponding tissue. However, these biopolymer-based hydrogels can
sometimes present a certain weakness and, more importantly, lack the adequate mechanical
properties that can be modified through either physically or chemically in situ cross-linking
reactions. Microbial polysaccharides, a renewable resource, have received great interest
in the TERM areas, particularly in producing new biomaterials. Recently, Kefiran-based
scaffolds were produced through a freeze gelation technique [16]. In previous research,
Kefiran, an exopolysaccharide produced by lactic acid bacteria from kefir grains, has re-
ceived particular attention for biomedical uses [16–18].
In the present work, Kefiran was chemically modified by reacting this polysaccha-
ride with methacrylic anhydride (MA) to be used in tissue engineering applications.
Thus, the obtained MA-Kefiran hydrogel was fully characterized for its structural,
physicochemical, and biological properties through a complete set of technologies such
as 1H-NMR (1H nuclear magnetic resonance spectroscopy), FTIR (Fourier-transform in-
frared spectroscopy), DSC (differential scanning calorimetry), GPC-SEC (gel permeation
chromatography − size exclusion chromatography), SEM (scanning electron microscopy),
micro-CT (micro-computed tomography), and rheology. The cytocompatibility of the
developed MA-Kefiran hydrogel was also evaluated by quantifying its hemolytic activity
and its impact on the metabolic activity of exposed L929 cells.
2. Materials and Methods
2.1. Production of Kefiran Polysaccharides
Kefiran exopolysaccharides were isolated from kefir grains as previously described by
our group [19]. These kefir grains were purchased locally from a household in Guimarães,
Portugal. Twenty grams of kefir grains were treated in water at 60 ◦C (1:10) for 30 min,
and the mixture was centrifuged at 18,300× g (20 min, 20 ◦C). From the supernatant,
the polysaccharide was precipitated by two volumes of cold ethanol and left at −20 ◦C
overnight, and a second centrifugation at 18,300× g (20 min, 4 ◦C) was performed.
Pellets were completely dissolved in water and this precipitation procedure was repeated
twice. Finally, the precipitates were re-dissolved in water (60 ◦C) and the obtained con-
centrated solution was the crude polysaccharide. The polysaccharide samples were finally
freeze-dried.
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2.2. Synthesis of Methacrylated Kefiran
Methacrylated Kefiran (MA-Kefiran) was synthesized by reacting the Kefiran polysac-
charide with methacrylic anhydride (MA) (Sigma-Aldrich Química S. L., Sintra, Portu-
gal) [19].The Kefiran polysaccharide (0.2 g) was dissolved into 20 mL of PBS (5 mM, pH 7.4)
and to this solution, 0.392 mL of MA was added. Then, the pH 8.5 of the solution was
continuously readjusted with a NaOH solution (1 M), and the reaction was continued
under constant stirring for 2.5 h. Finally, the MA-Kefiran solution was precipitated with
3 volumes of cold acetone and purified by dialysis for 7 days to remove the excess of MA
and acetone. The obtained MA-Kefiran samples were lyophilized.
2.3. Preparation of MA-Kefiran Scaffold
To produce MA-Kefiran cryogels, a MA-Kefiran polysaccharide solution was prepared
at a concentration of 2% (w/V) in ultrapure H2O. A total of 200 µL of the solution was
transferred to 96-well plate molds and placed immediately at −20 ◦C for 24 h and at 4 ◦C
for a further 24 h. Finally, the obtained Kefiran cryogels were freeze-dried.
2.4. Physicochemical Characterization of MA-Kefiran
2.4.1. H nuclear Magnetic Resonance Spectroscopy (NMR)
The chemical modification of Kefiran was assessed by 1H-NMR (Bruker, MA, USA).
The methacrylation degree (DM) which corresponds to the fraction of modified hydroxyl







Imethylene—Relative integration of the methylene proton peak of methacrylate groups;
ICH3—Relative integration of the methyl protons of the initial standard;
nmethylene—Number of protons in the CH2 = from the methacrylic group;
nCH3 —Number of protons in the CH2 = in the methyl groups of the Kefiran structure;
nOH—Number of reactive -OH sites per sugar residue in the Kefiran structure.
2.4.2. Fourier-Transform Infrared Spectroscopy (FTIR)
The transmission spectra of MA-Kefiran were acquired on an IR Prestige-21 spectrom-
eter (Shimadzu, Kyoto, Japan), using 32 scans, with a wavenumber range between 4000
and 600 cm−1 and a resolution of 4 cm−1.
2.4.3. Gel Permeation Chromatography—Size Exclusion Chromatography (GPC-SEC)
The molecular weight of MA-Kefiran was determined by GPC-SEC (Malvern Panalyt-
ical, Malvern, UK). The measurements were performed at 30 ◦C with a Malvern ViscoteK
TDA 305 by means of using refractometer, right and low angle light scattering and viscome-
ter detectors on a set of four columns: pre-column Suprema, 5 µm, 8 × 50, Suprema 30 Å,
5 µm, 8 × 300, and 2× Suprema 1000 Å, 5 µm 8 × 300. We have used PBS buffer saline
(0.01 M PBS, 0.0027 M KCl and 0.137 M NaCl, pH 7.4, at 25 ◦C) and 0.05% (w/V) NaN3 at a
rate of 1 mL/min. The absolute molecular weight was evaluated by a calibration of the LS
and RI detectors obtained using the Omnisec 5.12 software (ViskoteK) using pullulan (Mn,
48.8 kDa and PDI 1.07). The dn/dc of the polysaccharide was set to 0.15.
2.4.4. Differential Scanning Calorimetry (DSC)
The thermal analysis was carried out using a TA-Q100 equipment (Jasco, Tokyo, Japan).
MA-Kefiran samples (5–10 mg) were prepared and filled into aluminum pans. For DSC
reference, an empty aluminum pan was used and run simultaneously. Under a nitrogen
atmosphere, the samples were heated in two stages from 20 ◦C to 250 ◦C with a continuous
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rate of 20 ◦C /min; then were left during 2 min at this temperature, and then, they were
cooled at 20 ◦C /min to the initial temperature; a second heating run was conducted.
2.4.5. Rheology
A Kinexus pro + rheometer (Malvern Instruments, Malvern, UK) equipped with a
316-grade stainless steel cone-plate system composed by a plate lower pedestal and an
upper measurement geometry cone with 40 mm of diameter and 4◦ angle was used for
rheological analyses using the acquisition software rSpace. The following experiments
were conducted with MA-Kefiran samples at 1% (w/V) in H2O. The plots were obtained by
means of applying an average of experiments (n = 3).
The rotational experiment determines the shear viscosity as a function of the shear
rate, from 0.01 s−1 to 1000 s−1 at 37 ◦C.
The oscillatory experiment evaluates the viscoelasticity behavior of the material,
through frequency sweep curves.
The pull away experiment evaluates the adhesion properties of MA-Kefiran, by calculat-
ing the maximum force required to pull the plate away from the sample. The conditions of
the experiment were a gap speed of 1 mm/s, a contact force of 1 N and a contact time of 2 s.
2.4.6. Injectability Assay
The injectability test of the MA-Kefiran sample was carried out by an injection mea-
surement device. This equipment (KD Scientific, Leiria, Portugal) was composed of a
syringe pump where was placed a 1 mL disposable syringe with a needle gauge of 21,
and the assay was realized in extrusion mode with a rate of 1 mL/min.
2.4.7. Micro-Computed Tomography (Micro-CT) Analysis
The microstructure of the prepared MA-Kefiran scaffold (h 8 mm × d 5 mm) was
evaluated using a high-resolution X-ray microtomography system Skyscan 1272 scanner
(Bruker Micro-CT, Kontich, Belgium). Each MA-Kefiran sample was scanned using a pixel
size of 5 µm, a rotation site of 0.45◦ over a rotation range of 360◦. Images were acquired with
no filter, 50 kV X-ray source of energy, 200 µA current and a resolution of 2452 × 1640 pix-
els. A dynamic threshold of 20 was used to convert the reconstructed grey-scale images
into binary images that were then used for morphometric analysis by quantifying poros-
ity, interconnectivity, mean pore size and mean wall thickness (CT Analyzer v1.12.0.0,
SkyScan, Kontich, Belgium).The scaffold cross-sectional and longitudinal cuts and 3D
virtual models were also created, visualized and registered using the image processing and
reconstruction software’s Data Viewer (v1.6.6.0) and CT-Vox (v2.0.0) (SkyScan, Kontich,
Belgium), respectively.
2.4.8. Scanning Electron Microscopy (SEM)
MA-Kefiran scaffolds were fixed with carbon tape to aluminum stubs and platinum-
coated in a sputter coater (EM ACE600, Leica, Wentzler, Germany). Morphology im-
ages were obtained on a JSM-6010LV SEM (JEOL, Tokyo, Japan), featuring integrated
energy dispersive spectroscopy (EDS) (INCAx-Act, PentaFET Precision, Oxford Instru-
ments, Abingdon-on-Thames, UK).
2.5. Biological Characterization of MA-Kefiran
2.5.1. Hemolytic Assay
Five mL of rabbit blood (previously extracted with citrate dextrose) were added to
45 mL of PBS. During 10 min, the samples were harvested by centrifugation (1000× g, 4 ◦C)
and the supernatant was then discarded. This process was repeated two more times until
the PBS solution was clear, thus indicating that the pellet was clean. PBS was then added to
make a solution of 3% (w/V). Then, in each well of a 96-well plate, 80 µL of rabbit blood was
deposited along with 80 µL of each sample. Three wells, each containing blood with PBS
and Triton X-100 were used as negative and positive controls, respectively. During 4 h the
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plates were incubated at 37 ◦C, and afterwards centrifuged at 1000× g for 10 min, at 4 ◦C.
Finally, the supernatant (80 µL) of each well was transferred into a 96-well-U-bottom cell
culture plate and the absorbance at 558 nm (ABS) was measured. For each sample, data was
normalized with the controls, using the following formula:
Hemolysis (%) = [ (ABSsample/ABStriton) − 1] × 100 (2)
This research has been reviewed by the Animal Welfare Body of the School of Medicine
and its Life and Health Science Research Institute (EM/ICVS), and the Research Institute
on Biomaterials, Biodegradables and Biomimetics (I3Bs) - ORBEA EM/ICVS-I3Bs (Refer-
ence: ORBEA EM/ICVS-I3Bs_002/2019) as well as by the National Competent Authority
Direção-Geral de Alimentação e Veterinária (DGAV) (Reference: 0421/000/000/2020 -
022434). The research has been approved by ORBEA on November 13th of 2019 and by
DGAV on December 14th of 2020.
2.5.2. Cytotoxicity Assessment
The biocompatibility of MA-Kefiran was assessed using the L929 cell line, as described
in ISO 10993-5 (2009). In brief, 10,000 cells per well were seeded in 96-well plates and
a 4% (w/V) MA-Kefiran solution was prepared in 0.9% (w/V) of NaCl, as specified in
ISO 10993-12 (2012). The culture medium was composed of low-glucose Dulbecco’s
Modified Eagle Medium (DMEM, Sigma-Aldrich, Saint Louis, MO, USA) supplemented
with 10% (v/V) fetal bovine serum (FBS, Invitrogen, Carlsbad, CA, USA) and 1% (v/V)
antibiotic/antimycotic (Invitrogen). After 24 h, the culture medium of each well was
replaced for the Kefiran solution diluted in culture medium at a final concentration of
1% (v/V). A sample containing only culture medium was used as negative control and a
1% (v/V) Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) solution prepared in culture
medium was used as a positive control. Cultures were maintained at 37 ◦C under a
humidified atmosphere of 5% (v/V) CO2 in air. Finally, at 24 h, 48 h and 72 h of culture,
cell proliferation was assessed through the AlamarBlue® assay (Bio-Rad, Hercules, CA,
USA) and total double-stranded DNA (dsDNA) quantification.
Cell metabolic activity of L929 was assessed using the AlamarBlue® assay (Bio-Rad).
AlamarBlue® has resazurin in its composition, which is reduced to resorufin that upon
entering living cells results in a highly fluorescent compound that can be easily detected.
At each time point, the cell cultures were incubated with AlamarBlue® reagent (10% v/V) in
DMEM for 3 h at 37 ◦C. Cell suspensions were then distributed into wells of a 96-well black
plate, and fluorescence measurements were made using a Biotek Synergy HT microplate
reader with Ex/Em at 530/590 nm. To quantify the total dsDNA, at each time point,
the samples were collected and incubated for 1 h at 37 ◦C in ultrapure H2O, and then
stored at −80 ◦C until analyzed. Using the Quant-iT PicoGreen dsDNA kit (Molecular
Probes, Invitrogen) quantification assay, the dsDNA samples were directly transferred to a
96-well white plate where they were diluted and mixed with TE buffer. After the addition
of Quant-iT PicoGreen dsDNA reagent, samples were incubated at room temperature in
the dark and then fluorescence was measured with Ex/Em at 480/530 nm. A standard
DNA curve in the range of 1–2000 ng/mL was used to convert RFUs into ng/mL.
2.6. Statistical Analysis
Data analysis was performed utilizing the software Origin 2018 (Originlab Corpora-
tion, Northampton, MA, USA) for Windows. Shapiro–Wilk test (significance level of 0.05)
was used for the assessment of the normality of data. Comparisons between groups with
normal distribution were made using two-way ANOVA supplemented by Tukey’s test.
All data are expressed as mean ± standard deviation.
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3. Results
3.1. H-NMR
Quantitative NMR has become a widely used analytical tool for the quantification
of polysaccharides, being an important tool when evaluating the chemistry of these poly-
mers [20]. In our study, the chemical modification of Kefiran was assessed by 1H-NMR
(Figure 1a). The 1H-NMR spectrum revealed several anomeric α hydrogen, assigned to a
sugar on a lateral branch (Figure 1b), at the chemical shifts around 4.62 ppm, 4.67 ppm,
4.76 ppm, 4.78 ppm, 4.83 ppm, and 4.85 ppm. Furthermore, an anomeric β hydrogen
through a peak at 5.15 ppm was also observed. These data were also confirmed in a
previous research [19].






























FTIR has been used  to  identify  the  fundamental groups present  in polymer struc‐
tures; it represents a useful tool to study structural changes in polysaccharides, which is 
Figure 1. 1H nuclear magnetic resonance (1H-NMR) spectrum of methacrylated Kefiran (a) and
Kefiran (b) in deuterium oxide (D2O) at 60 ◦C. The vinyl groups of the methacrylic anhydride
(MA) were identified around δ 5.6–6.4 ppm (i) and the methyl group of MA was located around
δ 1.9 ppm (ii).
The methacrylation of Kefiran was confirmed through the 1H-NMR spectrum and the
degree of substitution obtained for the synthesized material MA-Kefiran was 47.6 ± 3.8%.
A previous study showed the methacrylation of the gellan gum (MA-GG) polysaccharide [4]
but the degree of substitution was considerably lower than that obtained in MA-Kefiran.
3.2. FTIR
FTIR has been used to identify the fundamental groups present in polymer structures;
it represents a us ful tool to study structural chang s in polysaccharid s, which is important
fo the evaluation of their biodegradability, biocompatibility, and biologic l response [21].
The FTIR spectrum has also proven the methacrylation of Kefiran by the appearance of the
carbon double bond peak at 1717 cm−1, identified in methacrylate groups but not in the
unmodified Kefiran polysaccharide (Figure 2).
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Figure 2. Fourier-transform infrared spectroscopy (FTIR) spectra of Kefiran (a) and methacrylated-
Kefiran (b). The shoulder appearing at 1717 cm−1 reveals the presence of the carbon double bond
ea f et acr late r s i t e ifie efira .
The use of polysaccharides for TERM is dependent on their biological and physical
properties; also, the presence of reactive chemical functional groups make polysaccharides
easily flexible to physical and chemical cross-linking, which turn them ideal biomaterials for
tissue engineering applications [22]. As previously demonstrated, the molecular structure
and component dynamics of materials were studied by NMR and FTIR.
3.3. DSC
DSC is the most employed thermal analysis tool to evaluate the thermophysical
and kinetic properties of materials with temperature. DSC is used to assess the heat
fusion, melting temperature, glass transition temperature, reaction energy and temperature,
denaturation temperature, among others [23]. Thus, MA-Kefiran was characterized to
assess its thermal stability (Figure 3).
Figure 3 presented the MA-Kefiran thermogram (endothermic heat flow); the function-
alized MA-Kefiran showed lower thermal stability than the native Kefiran polysaccharide
that previously reported a degradation temperature of 273 ◦C [19]. The observed differ-
ence between the native and the modified Kefiran regarding the thermal property is not
significant since the developed biomaterial will be used at physiological temperatures.
Recent studies, which developed an injectable, also used thermal analysis tools to
assess the molecular structure and purity of Kefiran polysaccharides extracted from com-
mercial and traditional kefir products. These hydrogels based on Kefiran were aimed
to be used as potential scaffolds for tissue regeneration or implantable drug delivery
devices [17,24].



































Figure 3. Differential scanning calorimetry (DSC) spectra of methacrylated-Kefiran showing a sharp
endothermic peak at 92 ◦C corresponding to the water evaporation of the sample, and an exothermic
peak at 159 ◦C that could be rel ted to the rapid decomposition behavior of MA-Kefiran.
3.4. GPC-SEC
This functionalized MA-Kefiran polymer presented a number-average molecular
weight and a weight-average molecular weight of 793 kDa and 620 kDa, respectively, and a
polydispersity index (PDI) of 1.3. It is important to highlight that the PDI, indicating the
distribution of polymer chain molecular weights, is usually in the range of 1.2 to 1.5 for
polysaccharides from natural resources.
The data obtained through GPC-SEC are considered significant parameters for the
biomaterial application. In fact, these data will define the physicochemical properties of
polymers such as solubility, viscosity, degradation, mechanical properties, among others,
and the particular application of a certain polymer will be related to these properties.
For example, a polymer with low molecular weight will have short degradation rate;
and the degradation rate of a biomaterial is commonly matched with the rate of tissue
regeneration. Moreover, a material with a high molecular weight will have a better thermal
stability even at very high temperatures, and will increase its mechanical properties [25–27].
3.5. Rheology of MA-Kefiran Extract
To perform the mechanical tests for the MA-Kefiran extract under simulated physio-
logical conditions the samples were measured immediately under 37 ◦C. The flow behavior
of a 1% (w/V) MA-Kefiran solution is illustrated in Figure 4. This plot shows data of the
shear viscosity measured as function of shear rate.
It has been shown that the viscosity declined as the shear rate augmented in MA-
Kefiran at 37 ◦C, which corresponds to a shear thinning fluid. This characteristic was also
observed previously in Kefiran solutions (1% and 10% w/V) at 37 ◦C [17].
This trend could be explained by the fact that polymers with large molecular chains
tumble randomly which will affect the polymer’s fluidity under low shear. Thus, the flow-
aligning effect of these biomolecules with the increase of shear will present less resistance
to the shear [28].
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Figure 4. Shear viscosity versus shear rate of m thacrylated-Kefiran at 1% (w/V). The indexes of
consistency (K, 0.003) and flow behavior (n, 1.118) in the power-law equation indicate a pseudoplas-
tic behavior.
From the perspective of an injectabl bi materi l for tissue engineering application,
the informati n obtained from the viscosity upon shear rate is important as it is highly
desirable that the viscosity of these biomaterials quickly decreases wh n exposed to the
increase of the shear te in order to ave low resistance du ing the injection process [29].
Mechanical properties ar evaluated in terms of storage and loss moduli, and ge str ngth.
In fact, as showed in this research, these properties can be modulated by changing the
molecular weight of the polymer through incorporation of additional compone ts.
3.6. Injectability Assay
Injectability is considered a key-product performance indicator for parenteral dosage
forms. This measurement refers to the performance of the formulatio during injectio .
In fact, this concept is an important parameter for specialized dosage forms, like suspen-
sions, injectable emulsions, microemulsions, liposomes, and microspheres [30]. In this work,
MA-Kefiran showed an extrusion force of 11.21 ± 2.87 N, a value similar to hyaluronic acid
(11.3 N) [17]. The latter polymer is gaining popularity as a viscosupplementation product
in the management of osteoarthritis (OA) [31]. Intra-articular injections have emerged as
a promising strategy of non-surgical treatment of an appreciable number of OA patients,
especially in those with mild-to-moderate OA [32].
3.7. Production of MA-Kefiran Scaffolds
Tissue engineering also contributes to the regeneration and repair of injured tissues by
joining autologous cells with an adequate scaffold biomaterial. This scaffold acts as natural
template for TE in guiding the growth and the remodeling of new functional tissue [33].
Usually, the structure of the polymeric scaffold is not easy to evaluate in terms of pore
shape and size, particularly in three dimensions [34].
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3.8. Assessment of the MA-Kefiran Scaffolds’ Morphological Properties
In this research, to explore, visualize, and analyze in detail the 3D structure of the
MA-Kefiran scaffold, micro-CT and SEM were used as powerful platforms [35].
3.8.1. Micro-CT
The key parameters to consider when optimizing a scaffold is to create a biomate-
rial with balanced biological and physical properties with certain structural parameters
regarding porosity, pore morphology, pore size and pore distribution [36]. In this work,
the pore diameter and distribution of the developed MA-Kefiran scaffold were evaluated
by micro-CT. The data obtained revealed a high porosity for this scaffold (85.53 ± 0.15%)
(Figure 5).
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wall  thickness and pore size of  the MA‐Kefiran scaffold  (85.5%, 11.9 μm and 33.7 μm, 
Figure 5. Morphology of methacrylated-kefiran scaffolds after freeze-drying. (A) Macroscopic image (scale bar: 1 mm);
(B) scanning electron microscopy (SEM) microstructure of surface at ×250 of magnification: longitudinal section (i);
cross section (ii); (C) 3D reconstructed MA-Kefir n scaffolds using the micro-computed tomography (CT) system: cross-
sectional (i, ii), longitudinal (iv, v) and fully recons ructed (iii) views (sc le bars: 500 µm); (D) micro-CT data: stru tu e
characterization (i) and pore size distribution (ii).
r t quantit ti a al si of icro- , it as possible to deter ine the porosity,
ic ess and pore size of the MA-Kefiran scaffold (85.5%, 11.9 µm and 33.7 µm, respec-
tively). Moreover, the high porosity and the high surface area to volume ratio are required
for homogeneous cell delivery, cellular attachment, and newly-formed tissue ingrowth [37].
Micropores (33 µm) such those observed in our research, are characterized by a larger
specific surface area, making cell attachment and protein adhesion on the 3D scaffold more
favorable, while larger and interconnected pores (macropores) improve cellularity and
ECM ingrowth for faster constructs development [38]. In soft tissue applications, pore sizes
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of 35 µm demonstrated success in promoting vascularization when compared to 20 µm
and 70 µm pores [33]. Moreover, a previous research revealed that the ideal pore size for
initial cell adhesion was 95 mm in vitro [39]. Though, in bone tissue engineering, the pore
range of 300–400 µm has been revealed to be more appropriate for osteoblast attachment,
proliferation, and differentiation [40]. It is noteworthy that, for cell infiltration and host
tissue ingrowth and vascularization, there is an optimal pore size range, such as 5 µm for
neovascularization [41], 5–15 µm for fibroblasts [42], 20–125 µm for adult mammalian skin
tissues [43], 40–100 µm for osteoid tissues [44] and 100–400 µm for bone tissues [45], for a
suitable implanted biomaterial.
The morphology and porosity characteristics such as their size, volume, intercon-
nectivity, shape, among others, must be cautiously tailored during scaffold production.
These properties are essential for new tissue regeneration, including building the cellular
network and interconnected pathways not only for oxygen, nutrient and regulatory factor
transportation, but also for cell signaling, differentiation and proliferation [46].
It is important to highlight that the equilibrium must be well-known between ob-
taining optimal cell attachment, proliferation and differentiation, thus facilitating the new
tissue growth [47].
3.8.2. SEM
SEM analysis, a precise tool, is considered one of the most widely used in TE [48].
SEM analysis of the MA-Kefiran scaffold showed a foam-like structure and a smooth
surface uniformly distributed. Figure 5 demonstrates the change in porosity and structure
in the chemically modified Kefiran polymer. Visually, the freeze-dried modified scaffold
has a more compact structure, which was verified by the data observed in SEM and micro-
CT. Moreover, it is important to reinforce that the pore after the freeze-drying process
reveals a very homogeneous structure and shows the ice-crystal morphology [49]. It is
well known that the architectural parameters of a suitable scaffold can be achieved by
various techniques that will provide a different level of control of pore size, distribution,
and connectivity; for instance, supercritical drying commonly leads to smaller pores
(usually meso and micropores) and in the other side, freeze–drying, which in turn leads to
macroporous structures [50]. Thus, it will be interesting to perform in the future different
processing methodologies, perhaps more advanced ones such as 3D printing or supercritical
fluid technologies, in order to optimize the scaffold’s performance for a certain TERM
application [13,51].
The morphology of the TE scaffold is a key aspect that affects the migration,
proliferation, and differentiation of cells. The ideal scaffold for TE is a biomaterial platform
with well-adjusted architectural, biological, mechanical and physical properties [52].
3.9. Rheology of MA-Kefiran Cryogel
The MA-Kefiran scaffold rheological behavior was evaluated in this research.
From Figure 6 it is possible to observe that the storage modulus is higher than the loss
modulus revealing the elastic character of the developed new scaffold.
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l tic behavior was quantified by the phase angle, which showed an average
value of 6.4. Besides, the s orage and loss m duli f the MA-Kefiran scaffold were almost
constant be ween 0.01 Hz and 1 Hz. It is important to point out hat besides th G′ and
G” increase, th av r g of the p ase angle was consta t until the end of the experim nt.
Moreover, the mechanical spe trum obtained (Figure 6), reveals a storage modulus higher
than the loss modulus, showing the elastic char cter of the - fir scaff l .
i ilar data were found with Kefiran scaffolds [16]. Considering the possible TERM
applications of MA-Kefiran, the data obtained through the echanical sti ulus derived
fro the dissipation energy ere obtained ith only 2 ( / ) - efiran concentra-
tions, revealing that the obtained data can be useful to i prove design strategies to create
functionalized Kefiran scaffolds with unique properties.
Regarding the adhesion properties of the A-Kefiran scaffold, it was shown that the
newly developed material exhibits robust adhesive behavior comparing to native Kefiran,
with values of 0.305 ± 0.067 N/s and 0.135 ± 0.049 N/s, respectively.
It is important to point out that hydrogels are complex hydrophilic polymer networks
containing a large amount of water, which results in a complex viscoelastic behavior.
These viscoelastic properties are one of the main features to take into consideration in some
tissues like bone. In fact, these viscoelastic mechanical properties are important, within the
physiological frequency ranges, and particularly over low strain rates [54]. The current
research highlighted the fact that the mechanical properties can be perfectly modulated
through chemical cross-linking.
3.10. Biocompatibility of MA-Kefiran Extracts
Biomaterial-based scaffolds need to be compatible with the cellular components
and endogenous cells in host tissues. Hemocompatibility testing of blood-contacting
biomaterials is important for a critical evaluation of their in vivo application. In fact,
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the degree of erythrocyte hemolysis is a key factor in evaluating the biocompatibility
of biomaterials [55].
For the hemocompatibility testing, the MA-Kefiran and Kefiran hydrogels were in-
cubated for 4 h with rabbit blood and then the samples were analyzed. According to the
American Society for Testing and Materials (ASTM), the materials should not produce a
negative effect on immune cells and, in this case, blood cells. According to ASTM, a bio-
material that only bursts 0% to 2% of the blood cells does not have a hemolytic effect.
Usually, an appropriate material should not generate more than 2% of hemolysis effect.
A higher hemolysis’s degree reveals poor biomaterial’s hemocompatibility [55]. The results
demonstrated that the tested Kefiran biopolymer and its modified product (MA-Kefiran)
did not present a hemolytic effect (Table 1).
Table 1. Hemolysis percentage of the methacrylated-Kefiran in contact with blood cells and corre-
sponding American Society for Testing and Materials (ASTM) classification.
Sample ASTM Classification (%)
MA-Kefiran 1.33 ± 0.21
Kefiran 2.00 ± 0.09
PBS 0
It is important to highlight that Kefiran and MA-Kefiran showed to be suitable bioma-
terials for medical applications. Nowadays, the hemocompatibility idea is to assure the
safety of the biomaterial and to reduce post-implant procedures which ultimately represent
a long-term benefit for the patient [56].
To be a proper biomaterial for in situ tissue regeneration, the chemically modified
Kefiran, MA-Kefiran, when in close connection with living tissue should not cause adverse
effects. The results of cell viability showed that the MA-Kefiran extract did not present any
significant cytotoxic effect on L929 cells at 24 h, 48 h, and 72 h (Figure 7).
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Figure 7. Methacrylated-Kefiran cytotoxicity using L929 cells. (A) Metabolic activity of L929 cells in contact with MA-
Kefiran extracts during 72 h (AlamarBlue® assay). (B) DNA quantification of L929 cells in contact with MA-Kefiran extracts
ring 72 h. Asterisks denote the significance levels obtained from the Tukey multiple comparison tests applied to the data
between time-points: p ≤ 0.01 (*), p ≤ 0.005 (**), and p ≤ 0.0 01 (***).
Figure 7 revealed that the L929 cells ere etabolically active in the presence of the
A-Kefiran and, their ability to gro in the ne condition increased during the ti e of
incubation. Therefore, it is important to point out that the degree of methacrylation of the
Kefiran polymer did not produce a deleterious effect on cellular metabolic activity; herein,
we have demonstrated that Kefiran can be chemically modified and remain biocompatible.
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In this research, the results revealed through these validated procedures that this
unique MA-Kefiran hydrogel should be evaluated, in the future, in animal models, a step
midway between in vitro studies and human clinical trials [57]. The in vivo assessment of
the developed hydrogel on OA animal models is currently being performed. The inflam-
matory response and biocompatibility will first be evaluated by subcutaneous injection
of this hydrogel in six weeks old BALB/c mouse. Then, OA will be induced in skeletally
mature rabbits though a partial lateral meniscectomy procedure and the therapeutic effect
of Kefiran based hydrogels on cartilage degeneration will be evaluated [58].
4. Conclusions
The chemical modification can impart specific structure and function to the Kefiran
biopolymer, attracting widespread attention for its biomedical applications. Thus, in this
research it has been shown that modification of the Kefiran polymer with methacrylic
anhydride is feasible and allows to successfully create a new MA-Kefiran hydrogel that
was fully characterized. Furthermore, it has been demonstrated that the modified hydro-
gel was biocompatible and showed an ability to improve cellular function of L929 cells.
MA-Kefiran hydrogels, with adjustable rheological properties, and remarkable morpho-
logical structure, could represent an interesting candidate for biomedical applications,
particularly in TE. Although significant achievements have been made in this research,
the application of MA-Kefiran hydrogels in biomedical applications is still emerging and
needs further improvement.
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